{
  "DOI": "10.1186/s40246-023-00480-w",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-023-00480-w",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eSuper-enhancers (SEs), driving high-level expression of genes with tumor-promoting functions, have been investigated recently. However, the roles of super-enhancer-associated lncRNAs (SE-lncRNAs) in tumors remain undetermined, especially in gliomas. We here established a SE-lncRNAs expression-based prognostic signature to choose the effective treatment of glioma and identify a novel therapeutic target.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eCombined analysis of RNA sequencing (RNA-seq) data and ChIP sequencing (ChIP-seq) data of glioma patient-derived glioma stem cells (GSCs) screened SE-lncRNAs. Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) datasets served to construct and validate SE-lncRNA prognostic signature. The immune profiles and potential immuno- and chemotherapies response prediction value of the signature were also explored. Moreover, we verified the epigenetic activation mechanism of LINC00945 via the ChIP assay, and its effect on glioma was determined by performing the functional assay and a mouse xenograft model.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003e6 SE-lncRNAs were obtained and identified three subgroups of glioma patients with different prognostic and clinical features. A risk signature was further constructed and demonstrated to be an independent prognostic factor. The high-risk group exhibited an immunosuppressive microenvironment and was higher enrichment of M2 macrophage, regulatory T cells (Tregs), and Cancer-associated fibroblasts (CAFs). Patients in the high-risk group were better candidates for immunotherapy and chemotherapeutics. The SE of LINC00945 was further verified via ChIP assay. Mechanistically, BRD4 may mediate epigenetic activation of LINC00945. Additionally, overexpression of LINC00945 promoted glioma cell proliferation, EMT, migration, and invasion in vitro and xenograft tumor formation in vivo.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eOur study constructed the first prognostic SE-lncRNA signature with the ability to optimize the choice of patients receiving immuno- and chemotherapies and provided a potential therapeutic target for glioma.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "480"
  ],
  "article-number": "33",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "13 December 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "25 March 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "31 March 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "All patients consented to an institutional review board-approved protocol that allows comprehensive analysis of tumor samples (Ethics committee of the Second Affiliated Hospital of Anhui Medical University). This study conforms to the Declaration of Helsinki."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declared that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Yang",
      "given": "Zhihao",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Zheng",
      "given": "Yinfei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wu",
      "given": "Haoyuan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xie",
      "given": "Han",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhao",
      "given": "Jiajia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chen",
      "given": "Zhigang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Lianxin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yue",
      "given": "Xiaoyu",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhao",
      "given": "Bing",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bian",
      "given": "Erbao",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        4,
        4
      ]
    ],
    "date-time": "2023-04-04T11:09:37Z",
    "timestamp": 1680606577000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        4
      ]
    ],
    "date-time": "2023-04-04T11:36:53Z",
    "timestamp": 1680608213000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        12
      ]
    ],
    "date-time": "2024-04-12T14:31:56Z",
    "timestamp": 1712932316524
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2023,
        3,
        31
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2023,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            3,
            31
          ]
        ],
        "date-time": "2023-03-31T00:00:00Z",
        "timestamp": 1680220800000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            3,
            31
          ]
        ],
        "date-time": "2023-03-31T00:00:00Z",
        "timestamp": 1680220800000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00480-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-023-00480-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-023-00480-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2023,
        3,
        31
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        3,
        31
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.critrevonc.2017.03.021",
      "author": "M Reni",
      "doi-asserted-by": "publisher",
      "first-page": "213",
      "journal-title": "Crit Rev Oncol Hematol",
      "key": "480_CR1",
      "unstructured": "Reni M, Mazza E, Zanon S, Gatta G, Vecht CJ. Central nervous system gliomas. Crit Rev Oncol Hematol. 2017;113:213–34.",
      "volume": "113",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00401-016-1545-1",
      "author": "DN Louis",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "issue": "6",
      "journal-title": "Acta Neuropathol",
      "key": "480_CR2",
      "unstructured": "Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.",
      "volume": "131",
      "year": "2016"
    },
    {
      "DOI": "10.3322/caac.21613",
      "author": "AC Tan",
      "doi-asserted-by": "publisher",
      "first-page": "299",
      "issue": "4",
      "journal-title": "CA Cancer J Clin",
      "key": "480_CR3",
      "unstructured": "Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 2020;70(4):299–312.",
      "volume": "70",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.ccell.2020.09.004",
      "author": "I Kaymak",
      "doi-asserted-by": "publisher",
      "first-page": "28",
      "issue": "1",
      "journal-title": "Cancer Cell",
      "key": "480_CR4",
      "unstructured": "Kaymak I, Williams KS, Cantor JR, Jones RG. Immunometabolic Interplay in the Tumor Microenvironment. Cancer Cell. 2021;39(1):28–37.",
      "volume": "39",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41586-019-1906-8",
      "author": "F Petitprez",
      "doi-asserted-by": "publisher",
      "first-page": "556",
      "issue": "7791",
      "journal-title": "Nature",
      "key": "480_CR5",
      "unstructured": "Petitprez F, de Reynies A, Keung EZ, Chen TW, Sun CM, Calderaro J, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577(7791):556–60.",
      "volume": "577",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fimmu.2021.629519",
      "author": "D Salem",
      "doi-asserted-by": "publisher",
      "first-page": "629519",
      "journal-title": "Front Immunol",
      "key": "480_CR6",
      "unstructured": "Salem D, Chelvanambi M, Storkus WJ, Fecek RJ. Cutaneous melanoma: mutational status and potential links to tertiary lymphoid structure formation. Front Immunol. 2021;12:629519.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41568-019-0224-7",
      "author": "JH Sampson",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "issue": "1",
      "journal-title": "Nat Rev Cancer",
      "key": "480_CR7",
      "unstructured": "Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer. 2020;20(1):12–25.",
      "volume": "20",
      "year": "2020"
    },
    {
      "DOI": "10.1126/science.aar4060",
      "author": "A Ribas",
      "doi-asserted-by": "publisher",
      "first-page": "1350",
      "issue": "6382",
      "journal-title": "Science",
      "key": "480_CR8",
      "unstructured": "Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–5.",
      "volume": "359",
      "year": "2018"
    },
    {
      "DOI": "10.1056/NEJMoa1414428",
      "author": "MA Postow",
      "doi-asserted-by": "publisher",
      "first-page": "2006",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "480_CR9",
      "unstructured": "Postow MA, Chesney J, Pavlick AC, Robert C, Grossmann K, McDermott D, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med. 2015;372(21):2006–17.",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1080/13696998.2020.1770261",
      "author": "RL Slater",
      "doi-asserted-by": "publisher",
      "first-page": "967",
      "issue": "9",
      "journal-title": "J Med Econ",
      "key": "480_CR10",
      "unstructured": "Slater RL, Lai Y, Zhong Y, Li H, Meng Y, Moreno BH, et al. The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States. J Med Econ. 2020;23(9):967–77.",
      "volume": "23",
      "year": "2020"
    },
    {
      "DOI": "10.1126/science.1259037",
      "author": "MR Mansour",
      "doi-asserted-by": "publisher",
      "first-page": "1373",
      "issue": "6215",
      "journal-title": "Science",
      "key": "480_CR11",
      "unstructured": "Mansour MR, Abraham BJ, Anders L, Berezovskaya A, Gutierrez A, Durbin AD, et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science. 2014;346(6215):1373–7.",
      "volume": "346",
      "year": "2014"
    },
    {
      "DOI": "10.1161/CIRCRESAHA.118.313788",
      "author": "V Kalna",
      "doi-asserted-by": "publisher",
      "first-page": "1337",
      "issue": "9",
      "journal-title": "Circ Res",
      "key": "480_CR12",
      "unstructured": "Kalna V, Yang Y, Peghaire CR, Frudd K, Hannah R, Shah AV, et al. The transcription factor ERG regulates super-enhancers associated with an endothelial-specific gene expression program. Circ Res. 2019;124(9):1337–49.",
      "volume": "124",
      "year": "2019"
    },
    {
      "DOI": "10.1093/nar/gkx1225",
      "author": "GJ Sanchez",
      "doi-asserted-by": "publisher",
      "first-page": "1756",
      "issue": "4",
      "journal-title": "Nucleic Acids Res",
      "key": "480_CR13",
      "unstructured": "Sanchez GJ, Richmond PA, Bunker EN, Karman SS, Azofeifa J, Garnett AT, et al. Genome-wide dose-dependent inhibition of histone deacetylases studies reveal their roles in enhancer remodeling and suppression of oncogenic super-enhancers. Nucleic Acids Res. 2018;46(4):1756–76.",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.cell.2013.09.053",
      "author": "D Hnisz",
      "doi-asserted-by": "publisher",
      "first-page": "934",
      "issue": "4",
      "journal-title": "Cell",
      "key": "480_CR14",
      "unstructured": "Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–47.",
      "volume": "155",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s12943-020-01162-0",
      "author": "K Liu",
      "doi-asserted-by": "publisher",
      "first-page": "54",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "480_CR15",
      "unstructured": "Liu K, Gao L, Ma X, Huang JJ, Chen J, Zeng L, et al. Long non-coding RNAs regulate drug resistance in cancer. Mol Cancer. 2020;19(1):54.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12943-020-01188-4",
      "author": "Z Huang",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "480_CR16",
      "unstructured": "Huang Z, Zhou JK, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19(1):77.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.semcancer.2020.12.012",
      "author": "EM McCabe",
      "doi-asserted-by": "publisher",
      "first-page": "38",
      "journal-title": "Semin Cancer Biol",
      "key": "480_CR17",
      "unstructured": "McCabe EM, Rasmussen TP. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 2021;75:38–48.",
      "volume": "75",
      "year": "2021"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-18-0367",
      "author": "L Peng",
      "doi-asserted-by": "publisher",
      "first-page": "572",
      "issue": "3",
      "journal-title": "Cancer Res",
      "key": "480_CR18",
      "unstructured": "Peng L, Jiang B, Yuan X, Qiu Y, Peng J, Huang Y, et al. Super-enhancer-associated long noncoding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma. Cancer Res. 2019;79(3):572–84.",
      "volume": "79",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12885-021-07900-x",
      "author": "L Yan",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "issue": "1",
      "journal-title": "BMC Cancer",
      "key": "480_CR19",
      "unstructured": "Yan L, Chen H, Tang L, Jiang P, Yan F. Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer. BMC Cancer. 2021;21(1):187.",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fonc.2021.745719",
      "author": "W Lv",
      "doi-asserted-by": "publisher",
      "first-page": "745719",
      "journal-title": "Front Oncol",
      "key": "480_CR20",
      "unstructured": "Lv W, Wang Y, Zhao C, Tan Y, Xiong M, Yi Y, et al. Identification and validation of m6A-related lncRNA signature as potential predictive biomarkers in breast cancer. Front Oncol. 2021;11:745719.",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fimmu.2021.706936",
      "author": "W Yu",
      "doi-asserted-by": "publisher",
      "first-page": "706936",
      "journal-title": "Front Immunol",
      "key": "480_CR21",
      "unstructured": "Yu W, Ma Y, Hou W, Wang F, Cheng W, Qiu F, et al. Identification of immune-related lncRNA prognostic signature and molecular subtypes for glioblastoma. Front Immunol. 2021;12:706936.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1111/cns.12220",
      "author": "R Li",
      "doi-asserted-by": "publisher",
      "first-page": "339",
      "issue": "4",
      "journal-title": "CNS Neurosci Ther",
      "key": "480_CR22",
      "unstructured": "Li R, Qian J, Wang YY, Zhang JX, You YP. Long noncoding RNA profiles reveal three molecular subtypes in glioma. CNS Neurosci Ther. 2014;20(4):339–43.",
      "volume": "20",
      "year": "2014"
    },
    {
      "DOI": "10.1002/sim.3148",
      "author": "W Sauerbrei",
      "doi-asserted-by": "publisher",
      "first-page": "5512",
      "issue": "30",
      "journal-title": "Stat Med",
      "key": "480_CR23",
      "unstructured": "Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med. 2007;26(30):5512–28.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1038/ncomms3612",
      "author": "K Yoshihara",
      "doi-asserted-by": "publisher",
      "first-page": "2612",
      "journal-title": "Nat Commun",
      "key": "480_CR24",
      "unstructured": "Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.",
      "volume": "4",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.celrep.2016.12.019",
      "author": "P Charoentong",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "issue": "1",
      "journal-title": "Cell Rep",
      "key": "480_CR25",
      "unstructured": "Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–62.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nmeth.3337",
      "author": "AM Newman",
      "doi-asserted-by": "publisher",
      "first-page": "453",
      "issue": "5",
      "journal-title": "Nat Methods",
      "key": "480_CR26",
      "unstructured": "Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.",
      "volume": "12",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41598-020-66986-8",
      "author": "M Yi",
      "doi-asserted-by": "publisher",
      "first-page": "10258",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "480_CR27",
      "unstructured": "Yi M, Nissley DV, McCormick F, Stephens RM. ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications. Sci Rep. 2020;10(1):10258.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13073-019-0638-6",
      "author": "F Finotello",
      "doi-asserted-by": "publisher",
      "first-page": "34",
      "issue": "1",
      "journal-title": "Genome Med",
      "key": "480_CR28",
      "unstructured": "Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11(1):34.",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s13059-016-1070-5",
      "author": "E Becht",
      "doi-asserted-by": "publisher",
      "first-page": "218",
      "issue": "1",
      "journal-title": "Genome Biol",
      "key": "480_CR29",
      "unstructured": "Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.7554/eLife.26476",
      "author": "J Racle",
      "doi-asserted-by": "publisher",
      "first-page": "e26476",
      "journal-title": "Elife",
      "key": "480_CR30",
      "unstructured": "Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 2017;6:e26476.",
      "volume": "6",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0001195",
      "author": "Y Hoshida",
      "doi-asserted-by": "publisher",
      "first-page": "e1195",
      "issue": "11",
      "journal-title": "PLoS ONE",
      "key": "480_CR31",
      "unstructured": "Hoshida Y, Brunet JP, Tamayo P, Golub TR, Mesirov JP. Subclass mapping: identifying common subtypes in independent disease data sets. PLoS ONE. 2007;2(11):e1195.",
      "volume": "2",
      "year": "2007"
    },
    {
      "DOI": "10.1093/nar/gks1111",
      "author": "W Yang",
      "doi-asserted-by": "publisher",
      "first-page": "D955",
      "journal-title": "Nucleic Acids Res",
      "key": "480_CR32",
      "unstructured": "Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41:D955–61.",
      "volume": "41",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13046-021-02129-9",
      "author": "E Bian",
      "doi-asserted-by": "publisher",
      "first-page": "337",
      "issue": "1",
      "journal-title": "J Exp Clin Cancer Res",
      "key": "480_CR33",
      "unstructured": "Bian E, Chen X, Cheng L, Cheng M, Chen Z, Yue X, et al. Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc. J Exp Clin Cancer Res. 2021;40(1):337.",
      "volume": "40",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fimmu.2021.749369",
      "author": "F Xu",
      "doi-asserted-by": "publisher",
      "first-page": "749369",
      "journal-title": "Front Immunol",
      "key": "480_CR34",
      "unstructured": "Xu F, Liu T, Zhou Z, Zou C, Xu S. Comprehensive analyses identify APOBEC3A as a genomic instability-associated immune prognostic biomarker in ovarian cancer. Front Immunol. 2021;12:749369.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkv1243",
      "author": "Y Wei",
      "doi-asserted-by": "publisher",
      "first-page": "D172",
      "issue": "D1",
      "journal-title": "Nucleic Acids Res",
      "key": "480_CR35",
      "unstructured": "Wei Y, Zhang S, Shang S, Zhang B, Li S, Wang X, et al. SEA: a super-enhancer archive. Nucleic Acids Res. 2016;44(D1):D172–9.",
      "volume": "44",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.cell.2016.12.013",
      "author": "JE Bradner",
      "doi-asserted-by": "publisher",
      "first-page": "629",
      "issue": "4",
      "journal-title": "Cell",
      "key": "480_CR36",
      "unstructured": "Bradner JE, Hnisz D, Young RA. Transcriptional addiction in cancer. Cell. 2017;168(4):629–43.",
      "volume": "168",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nature09504",
      "author": "P Filippakopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "1067",
      "issue": "7327",
      "journal-title": "Nature",
      "key": "480_CR37",
      "unstructured": "Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, et al. Selective inhibition of BET bromodomains. Nature. 2010;468(7327):1067–73.",
      "volume": "468",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41571-018-0003-5",
      "author": "M Lim",
      "doi-asserted-by": "publisher",
      "first-page": "422",
      "issue": "7",
      "journal-title": "Nat Rev Clin Oncol",
      "key": "480_CR38",
      "unstructured": "Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15(7):422–42.",
      "volume": "15",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.bbcan.2020.188353",
      "author": "M Cheng",
      "doi-asserted-by": "publisher",
      "first-page": "188353",
      "issue": "2",
      "journal-title": "Biochim Biophys Acta Rev Cancer",
      "key": "480_CR39",
      "unstructured": "Cheng M, Zhang ZW, Ji XH, Xu Y, Bian E, Zhao B. Super-enhancers: a new frontier for glioma treatment. Biochim Biophys Acta Rev Cancer. 2020;1873(2):188353.",
      "volume": "1873",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fonc.2022.779168",
      "author": "G Tanzhu",
      "doi-asserted-by": "publisher",
      "first-page": "779168",
      "journal-title": "Front Oncol",
      "key": "480_CR40",
      "unstructured": "Tanzhu G, Li N, Li Z, Zhou R, Shen L. Molecular subtypes and prognostic signature of pyroptosis-related lncRNAs in glioma patients. Front Oncol. 2022;12:779168.",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.3389/fgene.2021.678436",
      "author": "Y Cao",
      "doi-asserted-by": "publisher",
      "first-page": "678436",
      "journal-title": "Front Genet",
      "key": "480_CR41",
      "unstructured": "Cao Y, Zhu H, Tan J, Yin W, Zhou Q, Xin Z, et al. Development of an immune-related LncRNA prognostic signature for glioma. Front Genet. 2021;12:678436.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fonc.2020.586019",
      "author": "Q Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "586019",
      "journal-title": "Front Oncol",
      "key": "480_CR42",
      "unstructured": "Zhou Q, Yan X, Liu W, Yin W, Xu H, Cheng D, et al. Three immune-associated subtypes of diffuse glioma differ in immune infiltration, immune checkpoint molecules, and prognosis. Front Oncol. 2020;10:586019.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fonc.2022.930923",
      "author": "Y Zheng",
      "doi-asserted-by": "publisher",
      "first-page": "930923",
      "journal-title": "Front Oncol",
      "key": "480_CR43",
      "unstructured": "Zheng Y, Yue X, Fang C, Jia Z, Chen Y, Xie H, et al. A Novel defined endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune therapy in glioma. Front Oncol. 2022;12:930923.",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.1056/NEJMoa043331",
      "author": "ME Hegi",
      "doi-asserted-by": "publisher",
      "first-page": "997",
      "issue": "10",
      "journal-title": "N Engl J Med",
      "key": "480_CR44",
      "unstructured": "Hegi ME, Diserens A-C, Gorlia T, Hamou M-F, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997–1003.",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJMoa1407279",
      "author": "JE Eckel-Passow",
      "doi-asserted-by": "publisher",
      "first-page": "2499",
      "issue": "26",
      "journal-title": "N Engl J Med",
      "key": "480_CR45",
      "unstructured": "Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499–508.",
      "volume": "372",
      "year": "2015"
    },
    {
      "DOI": "10.1042/BSR20182179",
      "doi-asserted-by": "crossref",
      "key": "480_CR46",
      "unstructured": "Zhang C, Jing LW, Li ZT, Chang ZW, Liu H, Zhang QM, et al. Identification of a prognostic 28-gene expression signature for gastric cancer with lymphatic metastasis. Biosci Rep. 2019;39(5)."
    },
    {
      "DOI": "10.2147/NDT.S305182",
      "author": "X Li",
      "doi-asserted-by": "publisher",
      "first-page": "2073",
      "journal-title": "Neuropsychiatr Dis Treat",
      "key": "480_CR47",
      "unstructured": "Li X, Wang H. Long non-coding RNA GABPB1-AS1 augments malignancy of glioma cells by sequestering microRNA-330 and reinforcing the ZNF367/cell cycle signaling pathway. Neuropsychiatr Dis Treat. 2021;17:2073–87.",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.canlet.2019.01.008",
      "author": "B Wang",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "Cancer Lett",
      "key": "480_CR48",
      "unstructured": "Wang B, Zhao C-H, Sun G, Zhang Z-W, Qian B-M, Zhu Y-F, et al. IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65. Cancer Lett. 2019;447:93–104.",
      "volume": "447",
      "year": "2019"
    },
    {
      "DOI": "10.1177/17590914211001218",
      "author": "L Wei",
      "doi-asserted-by": "publisher",
      "first-page": "175909142110012",
      "journal-title": "ASN Neuro",
      "key": "480_CR49",
      "unstructured": "Wei L, Li L, Liu L, Yu R, Li X, Luo Z. Knockdown of annexin-A1 inhibits growth, migration and invasion of glioma cells by suppressing the PI3K/Akt signaling pathway. ASN Neuro. 2021;13:17590914211001218.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1155/2021/5549047",
      "author": "X Su",
      "doi-asserted-by": "publisher",
      "first-page": "5549047",
      "journal-title": "Oxid Med Cell Longev",
      "key": "480_CR50",
      "unstructured": "Su X, Yang Y, Guo C, Zhang R, Sun S, Wang Y, et al. NOX4-derived ROS mediates TGF-β1-induced metabolic reprogramming during epithelial-mesenchymal transition through the PI3K/AKT/HIF-1α pathway in glioblastoma. Oxid Med Cell Longev. 2021;2021:5549047.",
      "volume": "2021",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fonc.2022.983537",
      "author": "X Sun",
      "doi-asserted-by": "publisher",
      "first-page": "983537",
      "journal-title": "Front Oncol",
      "key": "480_CR51",
      "unstructured": "Sun X, Chen Y, Tao X, Zhang W, Wang X, Wang X, et al. INPP4B inhibits glioma cell proliferation and immune escape via inhibition of the PI3K/AKT signaling pathway. Front Oncol. 2022;12:983537.",
      "volume": "12",
      "year": "2022"
    },
    {
      "DOI": "10.15252/embr.201439246",
      "author": "MW Pickup",
      "doi-asserted-by": "publisher",
      "first-page": "1243",
      "issue": "12",
      "journal-title": "EMBO Rep",
      "key": "480_CR52",
      "unstructured": "Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243–53.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.7150/thno.29431",
      "author": "S Gao",
      "doi-asserted-by": "publisher",
      "first-page": "126",
      "issue": "1",
      "journal-title": "Theranostics",
      "key": "480_CR53",
      "unstructured": "Gao S, Yang D, Fang Y, Lin X, Jin X, Wang Q, et al. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy. Theranostics. 2019;9(1):126–51.",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1111/j.1582-4934.2010.01236.x",
      "author": "RV Iozzo",
      "doi-asserted-by": "publisher",
      "first-page": "1013",
      "issue": "5",
      "journal-title": "J Cell Mol Med",
      "key": "480_CR54",
      "unstructured": "Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med. 2011;15(5):1013–31.",
      "volume": "15",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.matbio.2017.03.004",
      "author": "P Ringer",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "Matrix Biol",
      "key": "480_CR55",
      "unstructured": "Ringer P, Colo G, Fässler R, Grashoff C. Sensing the mechano-chemical properties of the extracellular matrix. Matrix Biol. 2017;64:6–16.",
      "volume": "64",
      "year": "2017"
    },
    {
      "DOI": "10.1146/annurev-cellbio-111315-125341",
      "author": "EK Paluch",
      "doi-asserted-by": "publisher",
      "first-page": "469",
      "journal-title": "Annu Rev Cell Dev Biol",
      "key": "480_CR56",
      "unstructured": "Paluch EK, Aspalter IM, Sixt M. Focal adhesion-independent cell migration. Annu Rev Cell Dev Biol. 2016;32:469–90.",
      "volume": "32",
      "year": "2016"
    },
    {
      "DOI": "10.1002/path.5317",
      "author": "M Niklasson",
      "doi-asserted-by": "publisher",
      "first-page": "295",
      "issue": "3",
      "journal-title": "J Pathol",
      "key": "480_CR57",
      "unstructured": "Niklasson M, Bergstrom T, Jarvius M, Sundstrom A, Nyberg F, Haglund C, et al. Mesenchymal transition and increased therapy resistance of glioblastoma cells is related to astrocyte reactivity. J Pathol. 2019;249(3):295–307.",
      "volume": "249",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41568-019-0143-7",
      "author": "LN Kent",
      "doi-asserted-by": "publisher",
      "first-page": "326",
      "issue": "6",
      "journal-title": "Nat Rev Cancer",
      "key": "480_CR58",
      "unstructured": "Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326–38.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10585-013-9580-y",
      "author": "S Aravindan",
      "doi-asserted-by": "publisher",
      "first-page": "807",
      "issue": "6",
      "journal-title": "Clin Exp Metastasis",
      "key": "480_CR59",
      "unstructured": "Aravindan S, Natarajan M, Herman TS, Aravindan N. Radiation-induced TNFalpha cross signaling-dependent nuclear import of NFkappaB favors metastasis in neuroblastoma. Clin Exp Metastasis. 2013;30(6):807–17.",
      "volume": "30",
      "year": "2013"
    },
    {
      "DOI": "10.3390/cancers14143538",
      "author": "W Sun",
      "doi-asserted-by": "publisher",
      "first-page": "3538",
      "issue": "14",
      "journal-title": "Cancers",
      "key": "480_CR60",
      "unstructured": "Sun W, Zou Y, Cai Z, Huang J, Hong X, Liang Q, et al. Overexpression of NNMT in glioma aggravates tumor cell progression: an emerging therapeutic target. Cancers. 2022;14(14):3538.",
      "volume": "14",
      "year": "2022"
    },
    {
      "DOI": "10.1093/brain/awt025",
      "author": "A Golebiewska",
      "doi-asserted-by": "publisher",
      "first-page": "1462",
      "issue": "Pt 5",
      "journal-title": "Brain",
      "key": "480_CR61",
      "unstructured": "Golebiewska A, Bougnaud S, Stieber D, Brons NH, Vallar L, Hertel F, et al. Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain. 2013;136(Pt 5):1462–75.",
      "volume": "136",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nn.4185",
      "author": "D Hambardzumyan",
      "doi-asserted-by": "publisher",
      "first-page": "20",
      "issue": "1",
      "journal-title": "Nat Neurosci",
      "key": "480_CR62",
      "unstructured": "Hambardzumyan D, Gutmann DH, Kettenmann H. The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci. 2016;19(1):20–7.",
      "volume": "19",
      "year": "2016"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-14-1240",
      "author": "X Chen",
      "doi-asserted-by": "publisher",
      "first-page": "7285",
      "issue": "24",
      "journal-title": "Can Res",
      "key": "480_CR63",
      "unstructured": "Chen X, Zhang L, Zhang IY, Liang J, Wang H, Ouyang M, et al. RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. Can Res. 2014;74(24):7285–97.",
      "volume": "74",
      "year": "2014"
    },
    {
      "DOI": "10.1093/neuonc/nov157",
      "author": "DJ Silver",
      "doi-asserted-by": "publisher",
      "first-page": "153",
      "issue": "2",
      "journal-title": "Neuro Oncol",
      "key": "480_CR64",
      "unstructured": "Silver DJ, Sinyuk M, Vogelbaum MA, Ahluwalia MS, Lathia JD. The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities. Neuro Oncol. 2016;18(2):153–9.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-16-2598",
      "author": "C Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "6279",
      "issue": "20",
      "journal-title": "Clin Cancer Res",
      "key": "480_CR65",
      "unstructured": "Zhang C, Cheng W, Ren X, Wang Z, Liu X, Li G, et al. tumor purity as an underlying key factor in glioma. Clin Cancer Res. 2017;23(20):6279–91.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.molmed.2011.03.004",
      "author": "H Ogbomo",
      "doi-asserted-by": "publisher",
      "first-page": "433",
      "issue": "8",
      "journal-title": "Trends Mol Med",
      "key": "480_CR66",
      "unstructured": "Ogbomo H, Cinatl J Jr, Mody CH, Forsyth PA. Immunotherapy in gliomas: limitations and potential of natural killer (NK) cell therapy. Trends Mol Med. 2011;17(8):433–41.",
      "volume": "17",
      "year": "2011"
    },
    {
      "DOI": "10.1172/jci.insight.91487",
      "author": "C Gu-Trantien",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "11",
      "journal-title": "JCI Insight.",
      "key": "480_CR67",
      "unstructured": "Gu-Trantien C, Migliori E, Buisseret L, de Wind A, Brohee S, Garaud S, et al. CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight. 2017;2(11):1–18.",
      "volume": "2",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.omto.2021.07.006",
      "author": "Y Tang",
      "doi-asserted-by": "publisher",
      "first-page": "410",
      "journal-title": "Mol Ther Oncolytics",
      "key": "480_CR68",
      "unstructured": "Tang Y, Zhang AXJ, Chen G, Wu Y, Gu W. Prognostic and therapeutic TILs of cervical cancer—current advances and future perspectives. Mol Ther Oncolytics. 2021;22:410–30.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fimmu.2018.01004",
      "author": "Z Chen",
      "doi-asserted-by": "publisher",
      "first-page": "1004",
      "journal-title": "Front Immunol",
      "key": "480_CR69",
      "unstructured": "Chen Z, Hambardzumyan D. Immune microenvironment in glioblastoma subtypes. Front Immunol. 2018;9:1004.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.1111/cas.12015",
      "author": "Y Komohara",
      "doi-asserted-by": "publisher",
      "first-page": "2165",
      "issue": "12",
      "journal-title": "Cancer Sci",
      "key": "480_CR70",
      "unstructured": "Komohara Y, Horlad H, Ohnishi K, Fujiwara Y, Bai B, Nakagawa T, et al. Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci. 2012;103(12):2165–72.",
      "volume": "103",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature10169",
      "author": "A Facciabene",
      "doi-asserted-by": "publisher",
      "first-page": "226",
      "issue": "7355",
      "journal-title": "Nature",
      "key": "480_CR71",
      "unstructured": "Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, et al. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature. 2011;475(7355):226–30.",
      "volume": "475",
      "year": "2011"
    },
    {
      "DOI": "10.1186/s12943-018-0913-y",
      "author": "Y-A Wang",
      "doi-asserted-by": "publisher",
      "first-page": "168",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "480_CR72",
      "unstructured": "Wang Y-A, Li X-L, Mo Y-Z, Fan C-M, Tang L, Xiong F, et al. Effects of tumor metabolic microenvironment on regulatory T cells. Mol Cancer. 2018;17(1):168.",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.clineuro.2013.12.004",
      "author": "YC Ooi",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "journal-title": "Clin Neurol Neurosurg",
      "key": "480_CR73",
      "unstructured": "Ooi YC, Tran P, Ung N, Thill K, Trang A, Fong BM, et al. The role of regulatory T-cells in glioma immunology. Clin Neurol Neurosurg. 2014;119:125–32.",
      "volume": "119",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.cell.2018.01.009",
      "author": "S Su",
      "doi-asserted-by": "publisher",
      "first-page": "841",
      "issue": "4",
      "journal-title": "Cell",
      "key": "480_CR74",
      "unstructured": "Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell. 2018;172(4):841–56.",
      "volume": "172",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.drup.2020.100715",
      "author": "N Erin",
      "doi-asserted-by": "publisher",
      "first-page": "100715",
      "journal-title": "Drug Resist Updat",
      "key": "480_CR75",
      "unstructured": "Erin N, Grahovac J, Brozovic A, Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist Updat. 2020;53:100715.",
      "volume": "53",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13045-019-0770-1",
      "author": "T Liu",
      "doi-asserted-by": "publisher",
      "first-page": "86",
      "issue": "1",
      "journal-title": "J Hematol Oncol",
      "key": "480_CR76",
      "unstructured": "Liu T, Han C, Wang S, Fang P, Ma Z, Xu L, et al. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol. 2019;12(1):86.",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-13-1279",
      "author": "J Liang",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "480_CR77",
      "unstructured": "Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, et al. Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res. 2014;20(1):187–98.",
      "volume": "20",
      "year": "2014"
    },
    {
      "DOI": "10.3389/fimmu.2017.01349",
      "author": "M Massara",
      "doi-asserted-by": "publisher",
      "first-page": "1349",
      "journal-title": "Front Immunol",
      "key": "480_CR78",
      "unstructured": "Massara M, Persico P, Bonavita O, Poeta Mollica V, Locati M, Simonelli M, et al. Neutrophils in Gliomas. Front Immunol. 2017;8:1349.",
      "volume": "8",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ccell.2016.06.003",
      "author": "EW Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "324",
      "issue": "2",
      "journal-title": "Cancer Cell",
      "key": "480_CR79",
      "unstructured": "Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, et al. Critical role for CD103(+)/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell. 2016;30(2):324–36.",
      "volume": "30",
      "year": "2016"
    },
    {
      "DOI": "10.1002/jcp.27782",
      "author": "B Farhood",
      "doi-asserted-by": "publisher",
      "first-page": "8509",
      "issue": "6",
      "journal-title": "J Cell Physiol",
      "key": "480_CR80",
      "unstructured": "Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234(6):8509–21.",
      "volume": "234",
      "year": "2019"
    },
    {
      "DOI": "10.1158/2326-6066.CIR-15-0151",
      "author": "DA Reardon",
      "doi-asserted-by": "publisher",
      "first-page": "124",
      "issue": "2",
      "journal-title": "Immunocompet Model Cancer Immunol Res",
      "key": "480_CR81",
      "unstructured": "Reardon DA, Gokhale PC, Klein SR, Ligon KL, Rodig SJ, Ramkissoon SH, et al. Glioblastoma eradication following immune checkpoint blockade in an orthotopic. Immunocompet Model Cancer Immunol Res. 2016;4(2):124–35.",
      "volume": "4",
      "year": "2016"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-15-1535",
      "author": "JE Kim",
      "doi-asserted-by": "publisher",
      "first-page": "124",
      "issue": "1",
      "journal-title": "Clin Cancer Res",
      "key": "480_CR82",
      "unstructured": "Kim JE, Patel MA, Mangraviti A, Kim ES, Theodros D, Velarde E, et al. Combination therapy with anti-PD-1, Anti-TIM-3, and focal radiation results in regression of murine gliomas. Clin Cancer Res. 2017;23(1):124–36.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.critrevonc.2018.12.002",
      "author": "M Caccese",
      "doi-asserted-by": "publisher",
      "first-page": "128",
      "journal-title": "Crit Rev Oncol Hematol",
      "key": "480_CR83",
      "unstructured": "Caccese M, Indraccolo S, Zagonel V, Lombardi G. PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: a concise review. Crit Rev Oncol Hematol. 2019;135:128–34.",
      "volume": "135",
      "year": "2019"
    },
    {
      "DOI": "10.3390/cancers14010085",
      "author": "M Chen",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "issue": "1",
      "journal-title": "Cancers",
      "key": "480_CR84",
      "unstructured": "Chen M, Wang H, Guo H, Zhang Y, Chen L. Systematic investigation of biocompatible cationic polymeric nucleic acid carriers for immunotherapy of hepatocellular carcinoma. Cancers. 2021;14(1):85.",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1016/S1470-2045(17)30607-1",
      "author": "NL Syn",
      "doi-asserted-by": "publisher",
      "first-page": "e731",
      "issue": "12",
      "journal-title": "Lancet Oncol",
      "key": "480_CR85",
      "unstructured": "Syn NL, Teng MWL, Mok TSK, Soo RA. De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol. 2017;18(12):e731–41.",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1126/science.1160062",
      "author": "K Wing",
      "doi-asserted-by": "publisher",
      "first-page": "271",
      "issue": "5899",
      "journal-title": "Science",
      "key": "480_CR86",
      "unstructured": "Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science. 2008;322(5899):271–5.",
      "volume": "322",
      "year": "2008"
    },
    {
      "DOI": "10.1172/JCI87324",
      "author": "AI Daud",
      "doi-asserted-by": "publisher",
      "first-page": "3447",
      "issue": "9",
      "journal-title": "J Clin Invest",
      "key": "480_CR87",
      "unstructured": "Daud AI, Loo K, Pauli ML, Sanchez-Rodriguez R, Sandoval PM, Taravati K, et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest. 2016;126(9):3447–52.",
      "volume": "126",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nature13904",
      "author": "T Powles",
      "doi-asserted-by": "publisher",
      "first-page": "558",
      "issue": "7528",
      "journal-title": "Nature",
      "key": "480_CR88",
      "unstructured": "Powles T, Eder JP, Fine GD, Braiteh FS, Loriot Y, Cruz C, et al. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature. 2014;515(7528):558–62.",
      "volume": "515",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(17)31046-2",
      "author": "AB El-Khoueiry",
      "doi-asserted-by": "publisher",
      "first-page": "2492",
      "issue": "10088",
      "journal-title": "Lancet",
      "key": "480_CR89",
      "unstructured": "El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet. 2017;389(10088):2492–502.",
      "volume": "389",
      "year": "2017"
    },
    {
      "DOI": "10.1126/scitranslmed.aba5464",
      "author": "ME Raeber",
      "doi-asserted-by": "publisher",
      "first-page": "eaba5464",
      "issue": "561",
      "journal-title": "Sci Transl Med",
      "key": "480_CR90",
      "unstructured": "Raeber ME, Rosalia RA, Schmid D, Karakus U, Boyman O. Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity. Sci Transl Med. 2020;12(561):eaba5464.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nature13954",
      "author": "PC Tumeh",
      "doi-asserted-by": "publisher",
      "first-page": "568",
      "issue": "7528",
      "journal-title": "Nature",
      "key": "480_CR91",
      "unstructured": "Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJM, Robert L, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. 2014;515(7528):568–71.",
      "volume": "515",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S1470-2045(16)30498-3",
      "author": "CJ Langer",
      "doi-asserted-by": "publisher",
      "first-page": "1497",
      "issue": "11",
      "journal-title": "Lancet Oncol",
      "key": "480_CR92",
      "unstructured": "Langer CJ, Gadgeel SM, Borghaei H, Papadimitrakopoulou VA, Patnaik A, Powell SF, et al. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Lancet Oncol. 2016;17(11):1497–508.",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1111/febs.15325",
      "author": "H Li",
      "doi-asserted-by": "publisher",
      "first-page": "212",
      "issue": "1",
      "journal-title": "FEBS J",
      "key": "480_CR93",
      "unstructured": "Li H, Yan R, Chen W, Ding X, Liu J, Chen G, et al. Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor. FEBS J. 2021;288(1):212–28.",
      "volume": "288",
      "year": "2021"
    },
    {
      "DOI": "10.1111/jcmm.15788",
      "author": "W Chen",
      "doi-asserted-by": "publisher",
      "first-page": "11755",
      "issue": "20",
      "journal-title": "J Cell Mol Med",
      "key": "480_CR94",
      "unstructured": "Chen W, Li Q, Zhang G, Wang H, Zhu Z, Chen L. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis. J Cell Mol Med. 2020;24(20):11755–67.",
      "volume": "24",
      "year": "2020"
    },
    {
      "DOI": "10.1159/000486253",
      "author": "Y Gao",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "issue": "1",
      "journal-title": "Cell Physiol Biochem",
      "key": "480_CR95",
      "unstructured": "Gao Y, Yu H, Liu Y, Liu X, Zheng J, Ma J, et al. Long non-coding RNA HOXA-AS2 regulates malignant glioma behaviors and vasculogenic mimicry formation via the MiR-373/EGFR axis. Cell Physiol Biochem. 2018;45(1):131–47.",
      "volume": "45",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s11033-020-05371-0",
      "author": "T Shi",
      "doi-asserted-by": "publisher",
      "first-page": "2723",
      "issue": "4",
      "journal-title": "Mol Biol Rep",
      "key": "480_CR96",
      "unstructured": "Shi T, Guo D, Xu H, Su G, Chen J, Zhao Z, et al. HOTAIRM1, an enhancer lncRNA, promotes glioma proliferation by regulating long-range chromatin interactions within HOXA cluster genes. Mol Biol Rep. 2020;47(4):2723–33.",
      "volume": "47",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41419-020-03141-1",
      "author": "S Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "950",
      "issue": "11",
      "journal-title": "Cell Death Dis",
      "key": "480_CR97",
      "unstructured": "Zhang S, Wan H, Zhang X. LncRNA LHFPL3-AS1 contributes to tumorigenesis of melanoma stem cells via the miR-181a-5p/BCL2 pathway. Cell Death Dis. 2020;11(11):950.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12943-018-0915-9",
      "author": "B Donati",
      "doi-asserted-by": "publisher",
      "first-page": "164",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "480_CR98",
      "unstructured": "Donati B, Lorenzini E, Ciarrocchi A. BRD4 and cancer: going beyond transcriptional regulation. Mol Cancer. 2018;17(1):164.",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41556-020-0491-2",
      "author": "J Nishida",
      "doi-asserted-by": "publisher",
      "first-page": "465",
      "issue": "4",
      "journal-title": "Nat Cell Biol",
      "key": "480_CR99",
      "unstructured": "Nishida J, Momoi Y, Miyakuni K, Tamura Y, Takahashi K, Koinuma D, et al. Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis. Nat Cell Biol. 2020;22(4):465–75.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1073/pnas.2036346100",
      "author": "L Kuras",
      "doi-asserted-by": "publisher",
      "first-page": "13887",
      "issue": "24",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "480_CR100",
      "unstructured": "Kuras L, Borggrefe T, Kornberg RD. Association of the Mediator complex with enhancers of active genes. Proc Natl Acad Sci USA. 2003;100(24):13887–91.",
      "volume": "100",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.cell.2013.03.036",
      "author": "J Loven",
      "doi-asserted-by": "publisher",
      "first-page": "320",
      "issue": "2",
      "journal-title": "Cell",
      "key": "480_CR101",
      "unstructured": "Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, Vakoc CR, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320–34.",
      "volume": "153",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.cell.2018.10.042",
      "author": "A Boija",
      "doi-asserted-by": "publisher",
      "first-page": "1842",
      "issue": "7",
      "journal-title": "Cell",
      "key": "480_CR102",
      "unstructured": "Boija A, Klein IA, Sabari BR, Dall’Agnese A, Coffey EL, Zamudio AV, et al. Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell. 2018;175(7):1842–55.",
      "volume": "175",
      "year": "2018"
    }
  ],
  "reference-count": 102,
  "references-count": 102,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-023-00480-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}